Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical PracticeFrancesco Lasorsa, Giuseppe Lucarelli, Matteo Ferro et al.|Biomedicines|2023Cited by 161
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell CarcinomaFrancesco Lasorsa, Giuseppe Lucarelli, Octavian Sabin Tătaru et al.|Journal of Clinical Medicine|2023Cited by 129
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell CarcinomaFrancesco Lasorsa, Giuseppe Lucarelli, Loreto Gesualdo et al.|International Journal of Molecular Sciences|2023Cited by 98
The Role of MUC1 in Renal Cell CarcinomaMartina Milella, Giuseppe Lucarelli, Matteo Ferro et al.|Biomolecules|2024Cited by 59
Ischemia–Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic TargetsFrancesco Lasorsa, Giuseppe Lucarelli, Matteo Ferro et al.|International Journal of Molecular Sciences|2024Cited by 57